UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 15, 2017
Accession Number:
0001493152-17-005126
Submission Type:
POS AM
CIK:
0001362703
Company Name:
OncBioMune Pharmaceuticals, Inc
File Number:
333-208129